Notice of Preliminary Q1 2026 Earnings Announcement
-
PharmaResearch to announce preliminary consolidated Q1 2026 results on May 8, 2026 -
Results prepared under K-IFRS, are unaudited and subject to change -
Schedule may change due to company circumstances
KOSDAQ Filing Information
- Filing: Notice of Disclosure of Settlement Results
- Company: PharmaResearch (214450)
- Submission: PharmaResearch Co., Ltd.
- Receipt: 04-27-2026
- Under KRX KOSDAQ Market Division